IMMUNOGEN (IMGN) Covered Calls

IMMUNOGEN covered calls Immunogen, Inc. is focused on the development of therapeutics for the treatment of cancer using cancer biology, monoclonal antibodies and small molecule cytotoxic or cell-killing, agents.

You can sell covered calls on IMMUNOGEN to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IMGN (prices last updated Thu 4:16 PM ET):

IMMUNOGEN (IMGN) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.85 -0.01 8.57 9.19 1.4M - 1.3B
Covered Calls For IMMUNOGEN (IMGN)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Sep 21 9 0.50 8.69 3.6% 35.5%
Oct 19 9 0.75 8.44 6.6% 37.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

ImmunoGen, Inc. is a biotechnology company, which develops novel anticancer therapeutics using its antibody-drug conjugate technology. It also have developed engineered linkers that keep the payload firmly attached to the antibody while the whole therapy is circulating through the bloodstream and then release it once the therapy has reached and entered a cancer cell. The company also uses antibody-drug conjugate targeted antibody payload technology together with strong antibody expertise to develop its own product candidates. ImmunoGen was founded in March 1981 and is headquartered in Waltham, MA.